These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


116 related items for PubMed ID: 23528311

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. In vitro inhibition of matrix metalloproteinases, invasion and growth of Fanconi anemia human FANCA and FANCC lymphoblasts by nutrient mixture.
    Roomi MW, Bhanap B, Roomi NW, Niedzwiecki A, Rath M.
    Exp Oncol; 2014 Sep; 36(3):212-4. PubMed ID: 25265357
    [Abstract] [Full Text] [Related]

  • 3. Antitumor effect of ascorbic acid, lysine, proline, arginine, and green tea extract on bladder cancer cell line T-24.
    Roomi MW, Ivanov V, Kalinovsky T, Niedzwiecki A, Rath M.
    Int J Urol; 2006 Apr; 13(4):415-9. PubMed ID: 16734861
    [Abstract] [Full Text] [Related]

  • 4. Anti-angiogenic effects of a nutrient mixture on human umbilical vein endothelial cells.
    Roomi MW, Ivanov V, Kalinovsky T, Niedzwiecki A, Rath M.
    Oncol Rep; 2005 Dec; 14(6):1399-404. PubMed ID: 16273231
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of matrix metalloproteinase-2 secretion and invasion by human ovarian cancer cell line SK-OV-3 with lysine, proline, arginine, ascorbic acid and green tea extract.
    Roomi MW, Ivanov V, Kalinovsky T, Niedzwiecki A, Rath M.
    J Obstet Gynaecol Res; 2006 Apr; 32(2):148-54. PubMed ID: 16594917
    [Abstract] [Full Text] [Related]

  • 6. Antitumor effect of a combination of lysine, proline, arginine, ascorbic acid, and green tea extract on pancreatic cancer cell line MIA PaCa-2.
    Roomi MW, Ivanov V, Kalinovsky T, Niedzwiecki A, Rath M.
    Int J Gastrointest Cancer; 2005 Apr; 35(2):97-102. PubMed ID: 15879623
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Anticancer effect of lysine, proline, arginine, ascorbic acid and green tea extract on human renal adenocarcinoma line 786-0.
    Roomi MW, Ivanov V, Kalinovsky T, Niedzwiecki A, Rath M.
    Oncol Rep; 2006 Nov; 16(5):943-7. PubMed ID: 17016575
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Inhibition of malignant mesothelioma cell matrix metalloproteinase production and invasion by a novel nutrient mixture.
    Roomi MW, Ivanov V, Kalinovsky T, Niedzwiecki A, Rath M.
    Exp Lung Res; 2006 Nov; 32(3-4):69-79. PubMed ID: 16754473
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Marked inhibition of growth and invasive parameters of head and neck squamous carcinoma FaDu by a nutrient mixture.
    Roomi MW, Roomi NW, Kalinovsky T, Rath M, Niedzwiecki A.
    Integr Cancer Ther; 2009 Jun; 8(2):168-76. PubMed ID: 19679626
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. In vivo and in vitro antitumor effects of nutrient mixture in murine leukemia cell line P-388.
    Roomi MW, Roomi NW, Bhanap B, Rath M, Niedzwiecki A.
    Exp Oncol; 2011 Jun; 33(2):71-7. PubMed ID: 21716202
    [Abstract] [Full Text] [Related]

  • 16. Anti-tumor effect of ascorbic acid, lysine, proline, arginine, and epigallocatechin gallate on prostate cancer cell lines PC-3, LNCaP, and DU145.
    Roomi MW, Ivanov V, Kalinovsky T, Niedzwiecki A, Rath M.
    Res Commun Mol Pathol Pharmacol; 2004 Jun; 115-116():251-64. PubMed ID: 17564322
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Inhibition of growth and expression of inflammation mediators in human leukemic cell line U-937 by a nutrient mixture.
    Roomi MW, Kalinovsky T, Roomi NW, Rath M, Niedzwiecki A.
    Exp Oncol; 2013 Sep; 35(3):180-6. PubMed ID: 24084455
    [Abstract] [Full Text] [Related]

  • 19. Anticancer effects of a specific mixture of nutrients in the multidrug-resistant human uterine sarcoma MES-SA/Dx5 and the drug-sensitive MES-SA cell lines.
    Roomi MW, Kalinovsky T, Roomi NW, Rath M, Niedzwiecki A.
    Oncol Rep; 2012 Jan; 27(1):17-27. PubMed ID: 21947138
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.